Who makes Placebo of Erdos capsule?

Placebo of Erdos capsule is developed by Kwang-Ha Yoo.

What development phase is Placebo of Erdos capsule in?

Placebo of Erdos capsule is FDA-approved (marketed).

Last reviewed 2026-04-22 · How we verify

Placebo of Erdos capsule

Kwang-Ha Yoo · FDA-approved active Small molecule

A placebo formulation containing no active pharmaceutical ingredient, used as a control comparator in clinical trials.

At a glance

Generic name	Placebo of Erdos capsule
Sponsor	Kwang-Ha Yoo
Modality	Small molecule
Phase	FDA-approved

Mechanism of action

Placebo products are inert formulations designed to match the appearance and administration route of an active drug while containing no therapeutic agent. They are used in randomized controlled trials to establish the baseline effect of treatment expectation and natural disease progression, allowing researchers to isolate the true pharmacological efficacy of the investigational drug being tested.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluate the Efficacy and Safety of Acute Bronchitis Symptoms Improvement for Bronpass Tab. Compared to Erdos Capsule (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Placebo of Erdos capsule CI brief — competitive landscape report
Placebo of Erdos capsule updates RSS · CI watch RSS
Kwang-Ha Yoo portfolio CI